Mapmygenome expands team, starts operations in Delhi-NCR

Access to North India markets will help in targeted efforts for raising awareness about genomics testing

expand1

Mapmygenome India announced the start of operations in Delhi-NCR beginning June 1, 2015 and an expanded team including changes in top management. This is their first team expansion following a Pre Series A round of USD 1.1 million funding in March 2015.

The strategic move to start operations in Delhi-NCR aims to close the gap by fulfilling an existing need for genomic testing and genetic counselling services in North India. The Delhi team will focus on more personalized and efficient genomics services there. Access to North India markets will also help in targeted efforts for raising awareness about genomics testing.

The new team in Delhi comprises Chief Medical Officer - Dr. Naveen Talwar, VP Business Development - Dr. Jaishree Srinivasan, senior genetic counselors, admin, and sales personnel. Additions to Hyderabad team include Sr. VP Operations - Wing Commander (Dr.) M.K. Bose and marketing team.

Ms. Anu Acharya, CEO of Mapmygenome, said, "A new office in Delhi-NCR is a key strategic move for us. With two offices and an expanded team, we are sure to see an exponential increase in sales and performance."

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

BusinessWire India.com - Healthcare & biotechnology

Bwi-logo

VIVO Healthcare Received Investment from ICCO of Netherlands

Wednesday, 15 Feb 2017   |   VIVO Healthcare

Business Wire IndiaVIVO Healthcare (“VIVO”) today announced that it has received a strategic investment

BusinessWire India.com - Pharmaceutical

Bwi-logo

Takeda Completes Acquisition of ARIAD Pharmaceuticals, Inc.

Friday, 17 Feb 2017   |   Takeda Pharmaceutical Company Limited

Business Wire India Takeda Pharmaceutical Company Limited (TSE:4502) (“Takeda”) announced the completion

BusinessWire India.com - Medical Devices

Bwi-logo

World's First Medically-Accurate Health Monitoring System Integrated in

Friday, 17 Feb 2017   |   Leman Micro Devices

Business Wire India Leman Micro Devices (LMD), the developer of accredited consumer healthcare products

US FDA Expands Approval of Tiotropium Respimat® for Maintenance Treatment

Friday, 17 Feb 2017   |   Boehringer Ingelheim

Business Wire India Boehringer Ingelheim announced that the U.S. Food and Drug Administration (FDA) approved

Takeda Completes Acquisition of ARIAD Pharmaceuticals, Inc.

Friday, 17 Feb 2017   |   Takeda Pharmaceutical Company Limited

Business Wire India Takeda Pharmaceutical Company Limited (TSE:4502) (“Takeda”) announced the completion

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email

X